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Abstract
Objective—Bacterial infection of the pin tract represents the most common complication
associated with external fixation. This study was designed to evaluate the antibacterial activity of
nitric oxide (NO) releasing xerogel films applied to commercially pure titanium pins in a rat
model.
Methods—Pins were coated with xerogel solution via a dip-coating procedure. Half of the
xerogel coated implant pins were modified into NO-donors and served as the NO releasing group
while the remaining pins were left unmodified to serve as non-NO releasing xerogel coated
controls. Acid etched pins served as uncoated controls. Animal selection was randomized and
every rat had one pin from each of the three groups randomly allocated to the 3rd, 4th, or 5th tail
vertebrae. Quantification of bacterial infection was performed 48 days post-operatively and the
tissue-implant interface was inspected for clinical signs of infection on days 14 and 28 post-
implantation.
Results—Pin tract bacterial colony counts of the NO releasing group (170K±181K) were
significantly lower than both the xerogel coated group (677K±675K) and the control group
(1,181K±2,717K) 48 days postoperatively (p<0.05). No significant difference in colony counts
were observed between the xerogel coated group and the control group. The NO releasing group
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also had significantly fewer clinical signs of infection than both the coated and the control groups
on postoperative day 28 (p<0.05).
Conclusion—The application of NO releasing xerogel coatings can inhibit bacterial colonization
of external fixation pins both during the initial postsurgical period and up to 48 days post-
implantation.
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Introduction
Bacterial infection of the pin tract represents the most common complication associated with
external fixation and has a reported incidence often greater than 50% and as high as 96%.1–
8 This infection, in-turn, may cause loosening of pins leading to necessary replacement or
removal, failure of fracture healing, osteomyelitis, and/or septic arthritis. Due to the frequent
impaired blood supply at the site of infected implant and concern over antibiotic serum
toxicity levels, recent research in the prevention of pin tract infection has shifted away from
systemic antibiotics to a focus on device coatings that inhibit or reduce initial bacterial
adhesion.9,10 Several anti-infective coatings have been developed that protect the surfaces
of implants from bacterial colonization, a known prerequisite for infection.11 Indeed,
coating implants with antibiotics and silver ion releasing compounds have shown positive
results in various studies.12–14 Unfortunately, increasing microbial resistance to silver ion
and antibiotics necessitates additional research into more effective antimicrobial agents and
local release strategies.15,16
It has been demonstrated that the impregnation of silicone polymers with antimicrobial
agents is better able to reduce bacterial adhesion than other passive devise coatings.17 For
example, Gu et al. reported that vancomycin-coated gold nanoparticles imparted a 64-fold
improvement in efficacy over simple vancomycin.18 Similarly, silver nanoparticle coatings
have shown greater antibacterial activity than silver ion (Ag+) in solution due to the direct
toxicity of the particles. While several studies have demonstrated that antibacterial
nanoparticles have great promise, the use of conventional antibiotics (vancomycin) or
classical antibacterial agents (Ag+) to cap such nanoparticles does not address bacterial
resistance concerns.12–14 To the dismay of health care providers, there is ever increasing
concern about both the highly selective nature of many antibiotic coatings and the rising
resistance to silver ion. In effort to combat these pitfalls, more effective active release
strategies are presently being sought.15,16
The use of xerogel films as a carrier device for anti-infectious agents represents a new
paradigm in the design of antibacterial therapeutics.19 Nitric oxide (NO), a diatomic free
radical that plays a central role in the natural immune system response to infection, has been
shown to represent an alternative approach in the design of antibacterial nanoparticles.20
Relative to traditional antibiotics, NO has a short half-life, permitting localized action
without systemic effects common to various conventional antibacterial agents.21 Recent
studies have established that nitric oxide is an important bioregulatory agent involved in
multiple physiological processes including vasodilatation, neurotransmission, angiogenesis,
and phagocytosis.22 It has also been shown to be a key regulator of osteogenic
differentiation of human mesenchymal bone marrow cells, playing a key role in bone tissue
engineering and fracture healing.23,24 Of greatest importance for the current investigation is
the capability of NO to functionally modifying key bacterial cell membrane adhesion
proteins that mediate cell-substrate interactions.25,26 The cytotoxicity of activated
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macrophages exposed to lipopolysaccharides and peptidoglycans of bacterial cell walls has
been linked to their production of the powerful oxidant peroxynitrite (ONOO−) which is
generated from macrophage produced superoxide (O2−) and NO.27 While the production of
O2− is immediate, NO synthesis may take several hours.28 With an additional NO source,
the oxidizing power of peroxynitrite could be utilized by leukocytes prior to endogenous NO
production during the initial 4–6 hour post-implantation period prior to adhesion and
colonization. While prevention of bacterial adhesion and biofilm formation on implanted
devices is the primary function of NO in this application, it is important to note that NO has
also been observed to induce the dispersal of bacteria in biofilms that are thought to play a
key role in the infection of external fixation pins.29 Nitric oxide has been shown to possess
broad spectrum antibacterial activity, primarily due to its reactive byproducts including
peroxynitrite (ONOO−) and dinitrogen trioxide (N2O3).30 Of importance, both Gram-
positive and Gram-negative bacteria have been found to be susceptible to gaseous NO,
including methicillin-resistant Staphylococcus aureus.31 Members of our group have
synthesized aminosilane-based xerogel films capable of storing large payloads of NO. These
xerogel films are able to spontaneously release tunable levels of NO under aqueous
conditions at physiological temperature and pH.32
The ability of NO-releasing xerogels to reduce fibrinogen-mediated adhesion of
Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli; three common
infective agents in external fixation, has been previously demonstrated.33 However, it has
not been determined whether these same benefits can be achieved in vivo by conferring NO-
releasing capability to percutaneous titanium implants. The purpose of this study is to
evaluate the anti-microbial effects of NO-releasing xerogel coatings when applied to
titanium external fixation pins in a rat model.
Materials and Methods
N-6-(aminohexyl) aminopropyltrimethoxysilane (AHAP3) and isobutyltrimethoxysilane
(BTMOS) were acquired from Gelest (Morrisville, PA) and stored under nitrogen. Ethanol
(absolute) and hydrochloric acid (HCl) were purchased from Fisher Scientific (Pittsburgh,
PA). Distilled water was purified to a resistivity of 18.2MΩ and a total organic content of
<5ppb using a Millipore Milli-Q Gradient A-10 water purification system (Bedford, MA).
NO, argon, and nitrogen gasses were obtained from Airgas National Welders (Morrisville,
NC). Commercially pure, grade 2 titanium was purchased from McMaster-Carr
(Robbinsville, NJ).
NO-releasing xerogel coated titanium implants
Nitric Oxide releasing xerogel films were applied to commercially pure titanium (cpTi) pins
in a process similar to that described by Nablo et al.34 In summary, xerogel solutions were
prepared by mixing ethanol (441µL), water (235µL), and 0.5 M HCl (40µL) followed by
dropwise addition of 470µL isobutyltrimethoxysilane (BTMOS). After mixing the solution
for 18 hours, 316µL N-(6-aminohexyl) aminopropyltrimethoxysilane (AHAP3) was added
and the solution was mixed an additional 24 hours. Each cpTi pin was first cleaned by
sonication in ethanol, acetone, and deionized water for 10 minutes each. They were then
placed in 50% v/v (18 Normal) sulfuric acid at 60°C for 30 minutes, being stirred
periodically to ensure that all surfaces were evenly exposed. Multiple bouts of copious
rinsing with deionized water were then performed before pins were sonicated in deionized
water for 20 minutes prior to being allowed to dry. To increase the adhesion strength of the
xerogel films to the titanium substrates, the surfaces of the pins were hydroxylated by
immersing them in “piranha” (a 3:1 ratio of concentrated sulfuric acid to 30% hydrogen
peroxide) for 10 minutes. Deionized water was again used for vigorous rinsing and two
additional bouts of 10 minute sonication.
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Fifteen of the pins were set aside and served as uncoated controls while the remaining 30
were coated with xerogel solution via a dip-coating procedure. The initial coating was
allowed to solidify into a xerogel prior to the application of a second coating. The xerogel-
coated titanium pins were then placed in an oven at 55°C for 24-hours followed by storage
in a desiccator. For half of the xerogel-coated implants, the secondary amines contained
within the aminosilane component of the film were converted to diazeniumdiolate NO-
donors via exposure to five atm NO for a period of three days and then flushed with Ar as
described in Nablo et al.34 The remaining pins were left unmodified to serve as non-NO
releasing, xerogel coated controls.
Determination of NO release characteristics
Nitric oxide release from the xerogel coated cpTi pins was characterized using a
chemiluminescent nitric oxide analyzer (Sievers 280; Boulder, CO). A two-point calibration
was performed using a Sievers NO zero filter (0ppm) and an NO gas standard (25.85ppm;
balance N2). The cpTi pins coated with diazeniumdiolate-modified xerogels were
submerged in a vessel containing 30mL deoxygenated phosphate buffered saline (PBS;
10mM; pH 7.4) kept at temperature 37°C. Nitrogen gas was continuously sparged through
the PBS at a flow rate of 80mL/min. An additional nitrogen flow of 120mL/min was
provided through the headspace of the vessel to match the instrumental collection rate of
200mL/min.
Stability of xerogel films
Following exposure to nitric oxide, cpTi pins coated with diazeniumdiolate-modified
xerogels (n = 3) were placed in 5mL phosphate buffered saline soak solutions incubated at
37°C. Pins were transferred to new soak solutions after fixed time intervals over a period of
6 weeks. Silicon concentrations in each of the soak solutions were analyzed using an
inductively coupled plasma optical emission spectrometer (ICP-OES; Teledyne Leeman
Prodigy High Dispersion ICP; Hudson, NH).
Study Design
The Institutional Animal Care and Use Committee granted approval for this study. In
accordance with approved protocol, a total of 15 female Sprague-Dawley retired breeder rats
were obtained from a commercial breeder (Charles River Laboratories, Raleigh, NC, USA)
with a mean weight of 429±51 g. Rats were placed under general anesthesia and 2mm
diameter threaded pins were surgically implanted in their 3rd, 4th, and 5th tail vertebrae.
Implant pins were randomly divided into 3 groups. Group 1; 2mm uncoated control pins.
Group 2; 2mm pins prepared with xerogel films. This group served as a reference for the
direct effects of xerogel coating. Group 3; 2mm pins prepared with NO releasing xerogel
films. Animal selection was randomized and every rat had one pin from each of the three
groups randomly allocated to the 3rd, 4th, or 5th tail vertebra location. Each pin was
implanted 10 threads (3mm) into the vertebrae with the exposed end protruding through the
dorsal skin of the tail approximately 6mm. Rats were sacrificed on postoperative day 48 for
microbiological analysis of the pin tract.
Surgical Procedure
Three days prior to undergoing surgery, each animal received 250 mg/kg of acetaminophen
elixir in their drinking water to accustom them to its taste. On the day of surgery, Isoflurane
anesthesia (1 to 5% to effect) was administered until the toe pinch reflex could no longer be
elicited and aseptic technique was used to drape the animal exposing only the dorsal aspects
of the 3rd, 4th, and 5th tail vertebrae. A 3mm incision was made through the skin and a
1.8mm hole was drilled through the dorsal cortex, medullary canal, and ventral cortex. A
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2mm diameter threaded titanium pin was manually screwed into the prepared cavity until the
final thread was flush with the outer surface of the dorsal cortex. A similar process was
performed to implant pins in the remaining two vertebrae. One pin from each of the 3 groups
was randomly implanted into each of the three vertebrae of each rat. Each of the three
wound sites were then splashed with 500uL of a 0.25% bupivacaine solution.
Quantitative Outcome Measures
On day 48 the animals were euthanized and weighed and microbiological analysis was
performed. Each pin was removed and placed in a 5mL centrifuge tube containing 1mL
sterile saline. The implant cavity was then swabbed for five seconds using a sterile
applicator. Great effort was made to establish uniform contact with all surfaces within the
cavity. The exposed area of the applicator was then placed in a centrifuge tube containing
1mL of sterile saline. Each tube containing either an extracted pin or a swab was vortexed
and a series of 1:10 dilutions was performed and 0.1mL of the diluent was plated on 5%
sheep blood trypticase soy agar and spread uniformly using a bent glass Pasteur pipette. The
plates were incubated at 37°C for twenty-four hours, after which time the number of colony
forming units (CFU’s) were counted. Only plates containing between 20 and 300 colonies
were considered valid. If more than one plate in each series had a valid number of colonies,
the average was calculated. Total CFU’s for each pin was determined by combining the
number of colonies grown from the extracted pin with the colonies grown from the pin tract
swab.
Qualitative Classification of Pin Tract Infections
On postoperative days 14 and 28 the degree of pin tract infection of each pin was evaluated
using photographs of the pins. The clinical appearance of each pin site photograph was
evaluated, specifically for signs of infection, by three independent observers who were
blinded to the implant group to which the pin belonged. This qualitative analysis of pin tract
appearance was accomplished through the administration of the novel 5-point Likert scale
seen in Figure 1. Of note, while adequately serving the needs of the current study, this scale
has not been formally validated.
Statistical Evaluation
A Kruskal-Wallis ANOVA on ranks test, a nonparametric method of analysis that does not
assume homoscedasticity, was used to compare bacterial colonization between groups as
bacterial growth is logarithmic in nature. Chi-square analysis was performed to compare the
qualitative infection scores of each group. This was accomplished by comparing the
frequency of pin tract appearance scores >3 between the three groups. P-values <0.05 were
considered significant.
Results
Nitric oxide release from diazeniumdiolate-modified xerogels on cpTi pins was
characterized in terms of total NO, maximum NO surface flux, and release duration. The
total amount of nitric oxide released from the xerogel films was 0.28±0.11 µmol cm−2. NO
release from the surface of the materials reached a maximum flux of 20±7 pmol cm−2 s−1.
After 4 hours, 50% of the total NO had been exhausted. After 3 days, an NO flux of 0.7
pmol cm−2 s−1 was detectable; however, no NO release could be detected after 7 days.
Using ICP-OES, it was determined that degradation of the diazeniumdiolate-modified
xerogels was negligible through 6 weeks (7.6±1.5µg Si cm−2). This mass corresponds to
<1.9% degradation of the coating over the entire implant period.
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All 15 rats survived until euthanization on postoperative day 48. There was no significant
difference between weight at surgery (414.8±38.2g) and day 48 weight 429.4±51.7g). At the
time of sacrifice, six of the 45 implanted pins had been displaced from their implant sites. Of
note, four of the pins were originally placed in the 5th tail vertebra, which was exposed to
the greatest amount of multidirectional loading during sitting and sleeping. Two of the
displaced pins were etched controls, two were xerogel coated, and two were NO releasing.
As a result, 39 pin/vertebrae units were used for analysis of bacterial colonization; 13 etched
controls, 13 xerogel controls, and 13 NO releasing.
Pin tract bacterial colony counts of the NO releasing group (170K±181K) were significantly
lower than both the xerogel coated group (677K±675K) and the control group (1,181K
±2,717K) 48 days postoperatively (p<0.05). No significant difference in colony counts were
observed between the xerogel coated group and the control group (Figure 2).
There was a high inter-rater intra-class correlation (ICC) of 0.75 in the qualitative rating of
the pin track appearance. There were no NO releasing pin tracts that were given an infection
score of >3 on postoperative day 28; the xerogel coated and control groups had 2 and 7 pins
score >3 respectively. The number of NO releasing pins scoring greater than 3 was
significantly lower (p<0.05) than both the number of xerogel coated and control pins scoring
> 3 even 28 days after surgery (Figure 3).
Discussion
Orthopaedic device related infections are acquired primarily during surgery or in the early
postoperative period and have been described to occurs in three phases.35,36 Immediately
after insertion plasma proteins rapidly coat the surface of the fixation pin implant. The initial
interaction between bacterial cells and the adsorbed protein layer is non-specific through a
combination of van der Waals, gravitational, and Coulombic forces.37 During Phase II,
bacterial membrane proteins and polysaccharides bind to the proteins on the device surface.
Certain bacterial species subsequently secrete a protective exopolysaccharide layer (i.e.,
form a biofilm) in Phase III which provides the constituent bacterial cells with increased
antibiotic resistance.38 Biofilm-related bacterial infections are exceedingly difficult to treat
with conventional systemic antibiotic therapies.39 Thus, the most promising anti-infective
strategies seek to inhibit bacterial adhesion prior to biofilm formation. While reducing
bacterial adhesion during the initial six hour period following implantation is particularly
important for avoiding infection in a contained environment40, it has been shown that the
rate of infection in exposed pin tracts directly correlates with post-implantation time.7, 41–
42 However, results of our study suggest that the high NO flux at early time points is
bactericidal and can reduce initial adhesion of bacteria to implant surfaces. This is likely
achieved by providing NO to leukocytes which can then synthesize peroxynitrite from
superoxide prior to the delayed endogenous production of NO. The prolonged release of low
levels of NO, though not in high enough concentration to be bactericidal as a sole agent,
may serve to modify bacteria that manage to adhere to the implant through the intermediates
discussed in addition to augmenting the host’s natural defense mechanisms to better
withstand continued bacterial insult throughout the implant period. Nitric oxide functionally
modifies key bacterial cell membrane adhesion proteins that mediate cell-substrate
interactions25,26,29 and has been shown to possess broad spectrum antibacterial activity
against S. aureus, S. epidermidis, and E. coli, the three most common infective agents in
external fixation.33
The ability of diazeniumdiolate-modified xerogel coatings to reduce platelet and bacterial
adhesion and its tissue and wound healing properties via NO release have previously been
evaluated in non orthopaedic implants.43,44 Herein, the anti-microbial properties of NO
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releasing xerogel coatings were evaluated in an orthopaedic external fixation pin implant rat
model. It has been demonstrated that pin tract infection rises proportionally with the length
of time that external fixation pins are in place.7, 41–42 As a result, although the initial
implant period is the most critical period in controlling biofilm formation, external fixation
is typically a protracted process and repeated assault of the implant/tissue interface by
bacteria throughout this period require that anti-microbial therapy be sustained. An
understanding these two distinct mechanisms of infection is why a lengthy implant period
was investigated and 48 days post-implantation was chosen as a clinically relevant endpoint.
Our study results suggest that NO releasing xerogel coatings can reduce bacterial
colonization of external fixation pins up to 48 days post-implantation, despite the fact that
the xerogel coatings have released the majority of their NO during the initial five days.
Additionally, qualitative evaluation of infection on postoperative day 28 revealed
significantly reduced signs of infection associated with NO releasing pins when compared to
controls. These results taken together suggest that NO releasing xerogel coatings can
minimize bacterial colonization of external fixation pins during the initial postsurgical
period and maintain their positive effects up to seven weeks postoperatively.
In addition to the probable mechanisms by which NO release influences implant infection
discussed previously, it is likely that NO works in part through the modification of cell-cell
signaling and is therefore able to exert its effects long after it is exhausted from the tissue/
implant interface. This role is supported by the fact that NO has been shown to
downregulate interleukin-6, macrophage chemoattractant protein-1 (MCP-1), and other pro-
inflammatory cytokines,45 thereby reducing the number of neutrophils recruited to the site.
It has also been proposed that nitrosated proteins could play a role in mediating
inflammation.46 During the immediate period after surgical implantation the level of NO
release is high enough that nitrosated proteins may be readily formed and are able to persist
much longer than the NO itself.
Evaluation of the NO release profile from diazeniumdiolate-modified xerogels on cpTi pins
demonstrated that approximately 50% of the total NO was released within the first four
hours. Additionally, three days after implant only trace amounts of NO flux persisted and
zero NO release continued beyond one week. The results of our study suggest that long-term
infection can be minimized through short-term NO release, possible mechanisms are
discussed above. In vivo evaluation of antimicrobial external fixation pin coatings have
previously shown limited results. Two studies investigating the effects of silver coated pins
compared to stainless steel pins showed no statistically significant differences in human
trials.8,47 The results of a goat model comparing lipid soluble hydroxyapatite/chlorhexidine
pin coatings to uncoated pins showed significantly reduced rates of infection.48 These
results were found only 14 days post-implantation however; and, as discussed, the length of
exposure plays a crucial role in the rate of infection observed. A prospective trial of
hydroxyapatite coated pins used in human subjects for a protracted period showed no
difference in infection rates when compared to uncoated pins.49 The lack of success of
previous coatings makes the ability of NO releasing xerogel coatings to significantly reduce
bacterial colonization of external fixation pins for up to 48 days even more exciting.
Limitations of the study include the use of an animal model which may respond differently
than human subjects. The immune system of a rat often appears more robust than that of a
human and may have resulted in lower rates of infection and pin loosening. The pins in our
study were also subject to lower loading forces when compared to pins attached to an
external fixator frame. Additionally, rat tail vertebrae do not provide as solid a fixation as
diaphyseal cortical bone where external fixation pins are typically implanted. This may
explain why six of the 45 pins were displaced from their implant sites at time of sacrifice
and may also have unforeseen influences on microbial growth. While not undertaken in this
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study, implant surface analysis with microscopy or other material characterization
techniques would provide beneficial information in future studies.
It is possible to tune the amount of NO flux from diazeniumdiolate-modified xerogels and
even achieve prolonged release of NO by altering the amount of aminosilane NO-donor
precursor (AHAP3) used in preparing the coatings.42 Additional studies are needed to
determine if the sustained release of NO for a longer period has a more profound effect on
infection rates six to eight weeks postoperatively. Experiments to elucidate the mechanism
by which NO prevents bacterial adhesion are currently underway. We hypothesize that
through intermediate species such as N2O3, N2O4, and OONO−, NO destroys the function of
bacterial proteins that mediate surface adhesion and bacterial membranes thereby reducing
bacterial colonization at implant site. It would be of great benefit for additional studies to
both determine the species of bacteria remaining at the pin site after such treatment and to
include a qualitative analysis of the pin site upon pin removal as this was not performed in
the current evaluation. Further work needs to be done in order to be certain that similar
results would be obtained with NO releasing coatings applied to non-acid etched titanium or
stainless steel pins as well as in other animal models and human subjects. Additionally,
interval removal of pins after varying implant periods would allow for better assessment of
when bacterial contamination of NO releasing xerogel coated pins specifically occurs and
would provide insight into improving infection prevention strategies.
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Scoring rubric used by three independent evaluators of pin tract infection on post-operative
days 14 & 28.
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Mean bacterial colony counts for each of the three pin groups. Total bacterial colonies
determed by combining the number of colonies grown from extracted pin with the colonies
grown from the swabbed pin tract.
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Qualitative analysis of pin tract infection as scored by three independent evaluators on post-
operative days 14 & 28. Values represent the total number of pins receiving scores 1–5 from
each of the evaluators combined (ie. each pin received a total of three scores). There was a
statistically significant difference (p=0.014) between the number of NO releasing pins
scoring >3 and the number of both the xerogel coated and control pins scoring >3 on day 28.
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